Contact
QR code for the current URL

Story Box-ID: 67291

MOLOGEN AG Königin-Luise-Str. 27 14195 Berlin, Germany http://www.mologen.com
Contact Dirk Simon +49 30 84178813
Company logo of MOLOGEN AG
MOLOGEN AG

EMEA grants MOLOGEN AG medicine status for their cell-based gene therapy

(PresseBox) (Berlin, )
MOLOGEN AG announces that they obtained medicine status for their cell-based gene therapy against kidney cancer. This status was granted by Innovation Task Force (ITF), a committee of the European medicines evaluation agency, EMEA.

Others than their proprietary DNA molecules MIDGE and dSLIM, cells are not a priori regarded as medicine, and therefore this notification is of utmost importance. It is a major step forward for further clinical development of this cancer therapy in Europe.

MOLOGEN employs for this type of cancer therapy human cells derived from their proprietary master cell banks. Such cells are severalfold gene modified jeoj WRUGQ ynkfpag yjf uuvoatbtlpuglru hb uLQXV.
The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.